Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hepatectomy × Methylprednisolone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia 59 Precursor Cell Lymphoblastic Leukemia-Lymphoma 54 Lymphoma 49 Burkitt Lymphoma 39 Lymphoma, Large B-Cell, Diffuse 37 Lymphoma, Follicular 37 Myelodysplastic Syndromes 34 Lymphoma, Non-Hodgkin 34 Multiple Myeloma 32 Leukemia, Myeloid, Acute 31 Leukemia, Myeloid, Chronic-Phase 30 Leukemia, Myeloid, Accelerated Phase 28 Lymphoma, Large-Cell, Immunoblastic 27 Leukemia, Lymphocytic, Chronic, B-Cell 27 Hodgkin Disease 22 Blast Crisis 22 Lymphoma, Mantle-Cell 21 Lymphoma, B-Cell, Marginal Zone 21 Graft vs Host Disease 21 Neoplasms, Plasma Cell 20 Myeloproliferative Disorders 20 Dendritic Cell Sarcoma, Interdigitating 20 Recurrence 19 Leukemia, Myelomonocytic, Chronic 17 Leukemia, Biphenotypic, Acute 17 Congenital Abnormalities 17 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 15 Anemia, Refractory, with Excess of Blasts 15 Primary Myelofibrosis 13 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 13

Interventions

Methylprednisolone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07507643 2026-04-02

A Study of Methylprednisolone in People Having Liver Surgery

Memorial Sloan Kettering Cancer Center

Phase 3 Recruiting

Hepatectomy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡